Injectable Drug Delivery Resources

1. Overcoming Wet Injection Challenges With Human-Centric Design 6/19/2024

   By understanding the causes of wet injections and employing effective mitigation strategies, we can design safer, more user-friendly, and more effective devices.

2. Lyophilized Products Are On The Rise: What You Need To Know 2/18/2022

   There is increased demand for lyophilization services in the manufacturing of new biologic drugs and injectable formulations as well as in change of formulation presentation.

3. A Lifecycle Management Strategy For Sterile Injectables 12/9/2022

   Gain insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another.

4. Wearable Injectors: An Alternative To Traditional Intravenous Administration 3/24/2022

   See a quick visual summary of findings from an early feasibility clinical study featuring a 2-5 mL wearable injector with a viscous placebo.

5. Containment Solutions To Help Emerging Biologic Companies 3/24/2023

   Set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.

6. Accelerating Gene Therapy With HITSCAN Platform 4/16/2025

   Battelle’s HIT SCAN™ platform accelerates gene therapy by rapidly designing, screening, and optimizing nanoparticle drug delivery systems using high-throughput robotics and machine learning.

7. Annex 1 – The Brave New World Of Regulatory Compliance 2/3/2023

   The revision to Annex 1 will become effective in August 2023. Explore the major changes and considerations along with the next steps to achieve Annex 1 Regulatory compliance.

8. Factors To Consider When Selecting A CDMO For Complex Injectables Development And Manufacture 3/1/2022

   The right CDMO partner will have specialized technologies for complex injectable development along with the equipment, facilities and operations to adopt GMP practices with a "laboratory setting."

9. Personalized Gene Therapy Is Here. The Next Challenge Is Manufacturing. 1/12/2026

   By focusing on approved processes rather than products, the industry can deliver custom genetic therapies rapidly and reliably to patients with ultra-rare diseases.

10. Vials Vs. Cryobags For Cryopreservation Of Therapeutically Relevant T Cells 7/20/2023

    Explore how COP 50 mL vials could serve as a basis for cell therapies and storage solution to help facilitate the manufacture and commercialization of cell products.